Ads
related to: merck pharmaceuticals
Search results
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 2 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 6 hours agoMerck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 5 hours agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 8 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 4 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 8 hours agoThe latest development comes after Merck announced an investment of more than €300m ($320.8m) in a...
Merck to Acquire EyeBio
Morningstar· 6 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com via Yahoo Finance· 19 hours agoInvesting.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the ...
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 1 day agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 22 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
